Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus

References

• Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310–350
   PubMed Web of Science ®Google Scholar
• Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781–803
   PubMed Web of Science ®Google Scholar
• Roilides E, Katsifa H, Walsh TJ. Pulmonary host defenses against Aspergillus fumigatus. Res Immunol 1998; 73: 454–465
   Google Scholar
• Bozza S, Gaziano R, Spreca A, et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 2002; 168: 1362–1371
   PubMed Web of Science ®Google Scholar
• Morrison BE, Park SJ, Mooney JM, Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 2003; 112: 1862–1870
   PubMed Web of Science ®Google Scholar
• Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993; 61: 1185–1193
   PubMed Web of Science ®Google Scholar
• Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Effects of granulocyte colony-stimulating factor and interferon-γ on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J Leukoc Biol 1995; 57: 651–656
   PubMed Web of Science ®Google Scholar
• Liles WC, Huang JE, van Burik JA, Bowden RA, Dale DC. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis 1997; 175: 1012–1015
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A, Morani C, Baldelli F, et al. Beneficial effect of recombinant human granulocyte colony-forming factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. J Infect Dis 1995; 171: 1448–1454
   PubMed Web of Science ®Google Scholar
• Rodriguez-Adrian LJ, Grazziutti ML, Rex JH, Anaissie EJ. The potential role of cytokine therapy for fungal infections in patients with cancer: Is recovery from neutropenia all that is needed?. Clin Infect Dis 1998; 26: 1270–1278
   PubMed Web of Science ®Google Scholar
• Roilides E, Blake C, Holmes A, Pizzo PA, Walsh TJ. Granulocyte-macrophage colony-stimulating factor and interferon-γ prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae. J Med Vet Mycol 1996; 34: 63–69
   PubMedGoogle Scholar
• Smith PD, Lamerson CL, Banks SM, et al. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis 1990; 161: 999–1005
   PubMed Web of Science ®Google Scholar
• Roilides E, Holmes A, Blake C, et al. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: Enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J Infect Dis 1994; 170: 894–899
   PubMed Web of Science ®Google Scholar
• Lyman CA, Garrett KF, Pizzo PA, Walsh TJ. Response of human polymorphonuclear leukocytes and monocytes to Trichosporon, beigelii: host defense against an emerging opportunistic pathogen. J Infect Dis 1994; 170: 1557–1565
   PubMed Web of Science ®Google Scholar
• Karbassi A, Becker JM, Foster JS, Moore RN. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: Evidence for augmented expression of mannose receptors. J Immunol 1987; 139: 417–421
   PubMed Web of Science ®Google Scholar
• Roilides E, Sein T, Holmes A, et al. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Infect Dis 1995; 172: 1028–1034
   PubMed Web of Science ®Google Scholar
• Vitt CR, Fidler JM, Ando D, Zimmerman RJ, Aukerman SL. Antifungal activity of rhM-CSF in models of acute and chronic candidiasis in the rat. J Infect Dis 1994; 169: 369–374
   PubMed Web of Science ®Google Scholar
• Wing EJ, Ampel NM, Waheed A, Shadduck RK. Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol 1985; 135: 2052–2056
   PubMedGoogle Scholar
• Gonzalez CE, Lyman CA, Lee S, et al. Recombinant human macrophage colony-stimulating factor augments pulmonary host defenses against Aspergillus fumigatus. Cytokine 2001; 15: 87–95
   PubMed Web of Science ®Google Scholar
• Kuhara T, Uchida K, Yamaguchi H. Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection. Antimicrob Agents Chemother 2000; 44: 19–23
   PubMed Web of Science ®Google Scholar
• Roilides E, Dimitriadou-Georgiadou A, Sein T, Kadiltzoglou I, Walsh TJ. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun 1998; 66: 5999–6003
   PubMed Web of Science ®Google Scholar
• Louie A, Baltch AL, Smith RP, et al. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect Immun 1994; 62: 2761–2772
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, Del Sero G, et al. Interleukin-4 causes susceptibility to invasive aspergillosis through suppression of protective type 1 responses. J Infect Dis 1999; 180: 1957–1968
   PubMed Web of Science ®Google Scholar
• Cenci E, Romani L, Mencacci A, et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993; 23: 1034–1038
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, Fe d Ostiani C, et al. Cytokine-and t helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998; 178: 1750–1760
   PubMed Web of Science ®Google Scholar
• Duong M, Oullet N, Simard M, et al. Kinetic studies of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressant in mice. J Infect Dis 1998; 178: 1472–1482
   PubMed Web of Science ®Google Scholar
• Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997; 176: 300–303
   PubMed Web of Science ®Google Scholar
• Borger P, Koeter GH, Timmerman JA, et al. Proteases from Aspergillus fumigatus induce (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms. J Infect Dis 1999; 180: 1267–1274
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, Casagrande A, et al. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J Infect Dis 2001; 184: 610–617
   PubMed Web of Science ®Google Scholar
• Roilides E, Dimitriadou A, Kadiltsoglou I, et al. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol 1997; 158: 322–329
   PubMed Web of Science ®Google Scholar
• Roilides E, Tsaparidou S, Kadiltsoglou I, et al. Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma interferon-independent pathway. Infect Immun 1999; 67: 3047–3050
   PubMed Web of Science ®Google Scholar
• Winn RM, Gil-Lamaignere C, Roilides E, et al. Selective effects of interleukin-15 on antifungal activity and interleukin-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus spp. J Infect Dis 2003; 188: 585–590
   PubMed Web of Science ®Google Scholar
• Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis 1999; 179: 1038–1041
   PubMed Web of Science ®Google Scholar
• Abzug MJ, Walsh TJ. Interferon-gamma and colony stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J 2004; 23: 769–773
   PubMed Web of Science ®Google Scholar
• Pasic S, Abinun M, Pistignjat B, et al. Aspergillus osteomyelitis in chronic granulomatous disease: treatment with recombinant gamma-interferon and itraconazole. Pediatr Infect Dis J 1996; 15: 833–834
   PubMed Web of Science ®Google Scholar
• Traynor TR, Huffnagle GB. Role of chemokines in fungal infections. Med Mycol 2001; 39: 41–50
   PubMed Web of Science ®Google Scholar
• Akira S. Mammalian toll-like receptors. Curr Opin Immunol 2003; 15: 5–11
   PubMed Web of Science ®Google Scholar
• Hoffmann JA, Reichhart JM. Drosophila innate immunity: an evolutionary perspective. Nature Immunol 2002; 3: 121–126
   PubMed Web of Science ®Google Scholar
• Wang JE, Warris A, Ellingsen EA, et al. Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun 2001; 69: 2402–2406
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of the toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059–3069
   PubMed Web of Science ®Google Scholar
• Netea MG, Warris A, Van der Meer JW, et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 2003; 188: 320–326
   PubMed Web of Science ®Google Scholar
• Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 1–23
   PubMed Web of Science ®Google Scholar
• Mansour MK, Levitz SM. Interactions of fungi with phagocytes. Curr Opin Microbiol 2002; 5: 359–365
   PubMed Web of Science ®Google Scholar
• Hamilton AJ, Holdon MD. Antioxidant systems in the pathogenic fungi of man and their role in virulence. Med Mycol 1999; 37: 375–389
   PubMed Web of Science ®Google Scholar
• Bronte V, Serafini P, Mazzoni PA, et al. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003; 24: 302–306
   PubMed Web of Science ®Google Scholar
• Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420: 182–186
   PubMed Web of Science ®Google Scholar
• Doni A, Peri G, Chieppa M, et al. Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. Eur J Immunol 2003; 33: 2886–2893
   PubMed Web of Science ®Google Scholar
• Cheng VC, Yuen KY, Chan WM, et al. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000; 30: 882–892
   PubMed Web of Science ®Google Scholar
• Roilides E, Kadiltsoglou I, Dimitriadou A, et al. Interleukin-4 suppresses antifungal activities of human monocytes against Candida albicans. FEMS Immunol Med Microbiol 1997; 19: 169–180
   PubMedGoogle Scholar
• Roilides E, Walsh TJ. Suppressive effects of interleukin-10 on human mononuclear phagocyte function against Candida albicans and Staphylococcus aureus. J Infect Dis 1998; 178: 589–592
   PubMedGoogle Scholar
• Roilides E, Katsifa H, Tsaparidou S, et al. Interleukin-10 suppresses phagocytic and antihyphal activities of human neutrophils. Cytokine 2000; 12: 379–387
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Whitcomb PO, Ravankar S, et al. Successful treatment of hepatosplenic candidiasis through repeated episodes of neutropenia. Cancer 1995; 76: 2357–2362
   PubMedGoogle Scholar
• Walsh TJ, Whitcomb T, Piscitelli S, et al. Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis. Antimicrob Agents Chemother 1997; 41: 1944–1948
   PubMed Web of Science ®Google Scholar
• Roilides E, Sein T, Schaufele T, Chanock SJ, Walsh TJ. Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis. J Infect Dis 1998; 178: 589–592
   PubMedGoogle Scholar
• Choi EH, Foster CB, Taylor JG, et al. Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J Infect Dis 2003; 187: 1153–1156
   PubMed Web of Science ®Google Scholar
• Roilides E, Sein T, Roden M, Schaufele R, Walsh TJ. Elevated serum concentrations of interleukin-10 in non-neutropenic patients with invasive aspergillosis. J Infect Dis 2001; 183: 518–520
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases. Clin Microbiol Rev 1997; 10: 611–636
   PubMed Web of Science ®Google Scholar
• Clemons KV, Brummer E, Stevens DA. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother 1994; 38: 460–464
   PubMed Web of Science ®Google Scholar
• Zhou P, Sieve MC, Bennett J, et al. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol 1995; 155: 785–795
   PubMed Web of Science ®Google Scholar
• Magee DM, Cox RA. Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect Immun 1996; 64: 3609–3613
   PubMed Web of Science ®Google Scholar
• Brieland JK, Jackson C, Menzel F, et al. Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus. Infect Immun 2001; 96: 1554–1560
   Google Scholar
• Puccetti P, Romani L, Bistoni F. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol 1995; 3: 237–240
   PubMed Web of Science ®Google Scholar
• Letterio JJ, Lehrnbecher T, Pollack G, et al. Invasive candidiasis stimulates hepatocyte and monocyte production of active transforming growth factor-beta. Inf Immun 2001; 69: 5115–5120
   Google Scholar
• Kim, HS,Choi, E,Lyman, CA,, et al. Microarray analysis of expression of genes encoding innate host defense molecules by human monocytes against Candida albicans. Program and Abstracts of the Tenth International Immunocompromised Host Symposium. Int J Infect Dis 2004; 8: S55; Abstr 098.
   Google Scholar
• Cortez, KJ (Oct 31–Nov 2, 2004) , Lyman, CA, Kim, HS, , et al. Kinetics of gene expression of innate host defense molecules in human monocytes infected with Aspergillus fumigatus. Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy.( in press) 2004., Washington, DC, .
   Google Scholar